TNRC18::RARA fusion and XPO1::TNRC18 fusion have been reported in variant APL and AML, respectively.19,20 However, the specific role of TNRC18 in cancer remains unclear and requires further investigation. Here, RARA is linked to acute promyelocytic leukemia.